LOAMU
ATRS

Lombard Odier Asset Management (USA)’s Antares Pharma, Inc. ATRS Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,044,980
Closed -$1.26M – 186
2015
Q4 		$1.26M Buy
1,044,980
+41,818
+4% +$58.2K 0.12% 132
2015
Q3 		$1.71M Buy
1,003,162
+3,162
+0.3% +$6.2K 0.15% 147
2015
Q2 		$2.08M Buy
+1,000,000
New +$2.42M 0.15% 147

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ATRS Position: Q1 2016 in Review

Lombard Odier Asset Management (USA) sold out of Antares Pharma, Inc. (ATRS) in Q1 2016, closing a stake of 1,044,980 shares — an estimated $1.26M sold.

Lombard Odier Asset Management (USA) first reported a position in ATRS in Q2 2015 and held it in 3 quarters. The position peaked at $2.08M in Q2 2015. 83 funds tracked by Wall St. Rank hold ATRS as of Q1 2016.

  • Lombard Odier Asset Management (USA) reported no remaining Antares Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 1,044,980 Antares Pharma, Inc. shares in Q1 2016, an estimated $1.26M.
  • Lombard Odier Asset Management (USA) first reported a position in Antares Pharma, Inc. in Q2 2015 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s Antares Pharma, Inc. position peaked at $2.08M in Q2 2015.
  • 83 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2016, filed 16 May 2016.